Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1997 Dec;6(5-6):295–302. doi: 10.1080/09629359791415

Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control

C Bolton 1
PMCID: PMC2365877  PMID: 18472862

Abstract

The blood-brain barrier (BBB) is composed of a continuous endothelial layer with pericytes and astrocytes in close proximity to offer homeostatic control to the neurovasculature. The human demyelinating disease multiple sclerosis and the animal counterpart experimental allergic encephalomyelitis (EAE) are characterized by enhanced permeability of the BBB facilitating oedema formation and recruitment of systemically derived inflammatory-type cells into target tissues to mediate eventual myelin loss and neuronal dysfunction. EAE is considered a useful model for examining the pathology which culminates in loss of BBB integrity and the disease is now proving valuable in assessing compounds for efficacy in limiting damage at neurovascular sites. The precise mechanisms culminating in EAE-induced BBB breakdown are unclear although several potentially disruptive mediators have been implicated and have been previously identified as potent effectors of cerebrovascular damage in non-disease related conditions of the central nervous system. The review considers evidence that common mechanisms may mediate cerebrovascular permeability changes irrespective of the initial insult and discusses therapeutic approaches for the control of BBB leakage in the demyelinating diseases.

Full Text

The Full Text of this article is available as a PDF (232.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARLOW C. F. A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis. J Neuropathol Exp Neurol. 1956 Apr;15(2):196–207. doi: 10.1097/00005072-195604000-00005. [DOI] [PubMed] [Google Scholar]
  2. Baker D., O'Neill J. K., Turk J. L. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol. 1991 May;134(2):505–510. doi: 10.1016/0008-8749(91)90321-2. [DOI] [PubMed] [Google Scholar]
  3. Banks W. A., Kastin A. J. Interactions between the blood-brain barrier and endogenous peptides: emerging clinical implications. Am J Med Sci. 1988 May;295(5):459–465. doi: 10.1097/00000441-198805000-00008. [DOI] [PubMed] [Google Scholar]
  4. Begley D. J., Squires L. K., Zloković B. V., Mitrović D. M., Hughes C. C., Revest P. A., Greenwood J. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem. 1990 Oct;55(4):1222–1230. doi: 10.1111/j.1471-4159.1990.tb03128.x. [DOI] [PubMed] [Google Scholar]
  5. Betz A. L., Firth J. A., Goldstein G. W. Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells. Brain Res. 1980 Jun 16;192(1):17–28. doi: 10.1016/0006-8993(80)91004-5. [DOI] [PubMed] [Google Scholar]
  6. Bodor N., Brewster M. E. Problems of delivery of drugs to the brain. Pharmacol Ther. 1982;19(3):337–386. doi: 10.1016/0163-7258(82)90073-0. [DOI] [PubMed] [Google Scholar]
  7. Bolton C., Flower R. J. The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci. 1989;45(1):97–104. doi: 10.1016/0024-3205(89)90441-4. [DOI] [PubMed] [Google Scholar]
  8. Bolton C., Gordon D., Turk J. L. A longitudinal study of the prostaglandin content of central nervous system tissues from guinea pigs with acute experimental allergic encephalomyelitis (EAE). Int J Immunopharmacol. 1984;6(2):155–161. doi: 10.1016/0192-0561(84)90011-0. [DOI] [PubMed] [Google Scholar]
  9. Bolton C., Parker D., McLeod J., Turk J. L. A study of the prostaglandin and thromboxane content of the central nervous tissues with the development of chronic relapsing allergic encephalomyelitis. J Neuroimmunol. 1986 Jan;10(3):201–208. doi: 10.1016/0165-5728(86)90102-5. [DOI] [PubMed] [Google Scholar]
  10. Bolton C., Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J Pharmacol Exp Ther. 1997 Jul;282(1):397–402. [PubMed] [Google Scholar]
  11. Bolton C., Turner A. M., Turk J. L. Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapse. J Neuroimmunol. 1984 Jun;6(3):151–159. doi: 10.1016/0165-5728(84)90002-x. [DOI] [PubMed] [Google Scholar]
  12. Brett J., Gerlach H., Nawroth P., Steinberg S., Godman G., Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med. 1989 Jun 1;169(6):1977–1991. doi: 10.1084/jem.169.6.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brightman M. W., Reese T. S. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969 Mar;40(3):648–677. doi: 10.1083/jcb.40.3.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brosnan C. F., Goldmuntz E. A., Cammer W., Factor S. M., Bloom B. R., Norton W. T. Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5915–5919. doi: 10.1073/pnas.82.17.5915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Brown W. J. The capillaries in acute and subacute multiple sclerosis plaques: a morphometric analysis. Neurology. 1978 Sep;28(9 Pt 2):84–92. doi: 10.1212/wnl.28.9_part_2.84. [DOI] [PubMed] [Google Scholar]
  16. Cervós-Navarro J., Kannuki S., Nakagawa Y. Blood-brain barrier (BBB). Review from morphological aspect. Histol Histopathol. 1988 Apr;3(2):203–213. [PubMed] [Google Scholar]
  17. Claudio L., Kress Y., Norton W. T., Brosnan C. F. Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am J Pathol. 1989 Dec;135(6):1157–1168. [PMC free article] [PubMed] [Google Scholar]
  18. Claudio L., Kress Y., Norton W. T., Brosnan C. F. Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am J Pathol. 1989 Dec;135(6):1157–1168. [PMC free article] [PubMed] [Google Scholar]
  19. Cross A. H., Misko T. P., Lin R. F., Hickey W. F., Trotter J. L., Tilton R. G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest. 1994 Jun;93(6):2684–2690. doi: 10.1172/JCI117282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cutler R. W., Lorenzo A. V., Barlow C. F. Brain vascular permeability to I-125 gamma globulin and leukocytes in allergic encephalomyelitis. J Neuropathol Exp Neurol. 1967 Oct;26(4):558–571. doi: 10.1097/00005072-196710000-00004. [DOI] [PubMed] [Google Scholar]
  21. Daniel P. M., Lam D. K., Pratt O. E. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis. J Neurol Sci. 1981 Nov-Dec;52(2-3):211–219. doi: 10.1016/0022-510x(81)90006-x. [DOI] [PubMed] [Google Scholar]
  22. Dux E., Joó F. Effects of histamine on brain capillaries. Fine structural and immunohistochemical studies after intracarotid infusion. Exp Brain Res. 1982;47(2):252–258. doi: 10.1007/BF00239384. [DOI] [PubMed] [Google Scholar]
  23. Gallego M. J., Lopez Farre A., Riesco A., Monton M., Grandes S. M., Barat A., Hernando L., Casado S., Caramelo C. A. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: effect of L-arginine. Am J Physiol. 1993 Mar;264(3 Pt 2):H708–H714. doi: 10.1152/ajpheart.1993.264.3.H708. [DOI] [PubMed] [Google Scholar]
  24. Garthwaite J., Garthwaite G., Palmer R. M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol. 1989 Oct 17;172(4-5):413–416. doi: 10.1016/0922-4106(89)90023-0. [DOI] [PubMed] [Google Scholar]
  25. Goldmuntz E. A., Brosnan C. F., Norton W. T. Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol. 1986 Dec 1;137(11):3444–3450. [PubMed] [Google Scholar]
  26. Goldstein G. W. Endothelial cell-astrocyte interactions. A cellular model of the blood-brain barrier. Ann N Y Acad Sci. 1988;529:31–39. doi: 10.1111/j.1749-6632.1988.tb51417.x. [DOI] [PubMed] [Google Scholar]
  27. Grossman R. I., Lisak R. P., Macchi P. J., Joseph P. M. MR of acute experimental allergic encephalomyelitis. AJNR Am J Neuroradiol. 1987 Nov-Dec;8(6):1045–1048. [PMC free article] [PubMed] [Google Scholar]
  28. Hartung H. P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J. J., Toyka K. V. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol. 1992 Oct;40(2-3):197–210. doi: 10.1016/0165-5728(92)90134-7. [DOI] [PubMed] [Google Scholar]
  29. Hawkins C. P., Mackenzie F., Tofts P., du Boulay E. P., McDonald W. I. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain. 1991 Apr;114(Pt 2):801–810. doi: 10.1093/brain/114.2.801. [DOI] [PubMed] [Google Scholar]
  30. Hawkins C. P., Munro P. M., Landon D. N., McDonald W. I. Metabolically dependent blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol. 1992;83(6):630–635. doi: 10.1007/BF00299413. [DOI] [PubMed] [Google Scholar]
  31. Hawkins C. P., Munro P. M., MacKenzie F., Kesselring J., Tofts P. S., du Boulay E. P., Landon D. N., McDonald W. I. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain. 1990 Apr;113(Pt 2):365–378. doi: 10.1093/brain/113.2.365. [DOI] [PubMed] [Google Scholar]
  32. Hedley-Whyte E. T., Hsu D. W. Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol. 1986 Apr;19(4):373–377. doi: 10.1002/ana.410190411. [DOI] [PubMed] [Google Scholar]
  33. Hirano A., Dembitzer H. M., Becker N. H., Levine S., Zimmerman H. M. Fine structural alterations of the blood-brain barrier in experimental allergic encephalomyelitis. J Neuropathol Exp Neurol. 1970 Jul;29(3):432–440. doi: 10.1097/00005072-197007000-00007. [DOI] [PubMed] [Google Scholar]
  34. Jung-Testas I., Renoir M., Bugnard H., Greene G. L., Baulieu E. E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):621–631. doi: 10.1016/0960-0760(92)90394-x. [DOI] [PubMed] [Google Scholar]
  35. Koenig H., Goldstone A. D., Lu C. Y. Blood brain barrier breakdown in brain edema following cold injury is mediated by microvascular polyamines. Biochem Biophys Res Commun. 1983 Nov 15;116(3):1039–1048. doi: 10.1016/s0006-291x(83)80247-2. [DOI] [PubMed] [Google Scholar]
  36. Koenig H., Goldstone A. D., Lu C. Y. Blood-brain barrier breakdown in cold-injured brain is linked to a biphasic stimulation of ornithine decarboxylase activity and polyamine synthesis: both are coordinately inhibited by verapamil, dexamethasone, and aspirin. J Neurochem. 1989 Jan;52(1):101–109. doi: 10.1111/j.1471-4159.1989.tb10903.x. [DOI] [PubMed] [Google Scholar]
  37. Koenig H., Trout J. J., Goldstone A. D., Lu C. Y. Capillary NMDA receptors regulate blood-brain barrier function and breakdown. Brain Res. 1992 Aug 21;588(2):297–303. doi: 10.1016/0006-8993(92)91589-7. [DOI] [PubMed] [Google Scholar]
  38. Kuharik M. A., Edwards M. K., Farlow M. R., Becker G. J., Azzarelli B., Klatte E. C., Augustyn G. T., Dreesen R. G. Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions. AJNR Am J Neuroradiol. 1988 Jul-Aug;9(4):643–648. [PMC free article] [PubMed] [Google Scholar]
  39. Kuroda Y., Shimamoto Y. Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J Neuroimmunol. 1991 Nov;34(2-3):159–164. doi: 10.1016/0165-5728(91)90125-q. [DOI] [PubMed] [Google Scholar]
  40. LAMPERT P., CARPENTER S. ELECTRON MICROSCOPIC STUDIES ON THE VASCULAR PERMEABILITY AND THE MECHANISM OF DEMYELINATION IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. J Neuropathol Exp Neurol. 1965 Jan;24:11–24. doi: 10.1097/00005072-196501000-00002. [DOI] [PubMed] [Google Scholar]
  41. Leibowitz S., Kennedy L. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. Immunology. 1972 May;22(5):859–869. [PMC free article] [PubMed] [Google Scholar]
  42. Linthicum D. S., Munoz J. J., Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol. 1982 Nov 1;73(2):299–310. doi: 10.1016/0008-8749(82)90457-9. [DOI] [PubMed] [Google Scholar]
  43. Long J. B., Holaday J. W. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science. 1985 Mar 29;227(4694):1580–1583. doi: 10.1126/science.3975627. [DOI] [PubMed] [Google Scholar]
  44. Lossinsky A. S., Badmajew V., Robson J. A., Moretz R. C., Wisniewski H. M. Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol. 1989;78(4):359–371. doi: 10.1007/BF00688172. [DOI] [PubMed] [Google Scholar]
  45. MacPhee I. A., Antoni F. A., Mason D. W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med. 1989 Feb 1;169(2):431–445. doi: 10.1084/jem.169.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Mannie M. D., Pope L., Paterson P. Y. Indomethacin augments in vitro proliferative responses of Lewis rat lymphocytes to myelin basic protein. Implications for experimental autoimmune encephalomyelitis. Cell Immunol. 1989 Jun;121(1):196–212. doi: 10.1016/0008-8749(89)90017-8. [DOI] [PubMed] [Google Scholar]
  47. Miller D. H., Rudge P., Johnson G., Kendall B. E., Macmanus D. G., Moseley I. F., Barnes D., McDonald W. I. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 1988 Aug;111(Pt 4):927–939. doi: 10.1093/brain/111.4.927. [DOI] [PubMed] [Google Scholar]
  48. Moor A. C., de Vries H. E., de Boer A. G., Breimer D. D. The blood-brain barrier and multiple sclerosis. Biochem Pharmacol. 1994 May 18;47(10):1717–1724. doi: 10.1016/0006-2952(94)90297-6. [DOI] [PubMed] [Google Scholar]
  49. Morrissey S. P., Stodal H., Zettl U., Simonis C., Jung S., Kiefer R., Lassmann H., Hartung H. P., Haase A., Toyka K. V. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain. 1996 Feb;119(Pt 1):239–248. doi: 10.1093/brain/119.1.239. [DOI] [PubMed] [Google Scholar]
  50. Namer I. J., Steibel J., Poulet P., Armspach J. P., Mohr M., Mauss Y., Chambron J. Blood-brain barrier breakdown in MBP-specific T cell induced experimental allergic encephalomyelitis. A quantitative in vivo MRI study. Brain. 1993 Feb;116(Pt 1):147–159. doi: 10.1093/brain/116.1.147. [DOI] [PubMed] [Google Scholar]
  51. Nathan C. F. Secretory products of macrophages. J Clin Invest. 1987 Feb;79(2):319–326. doi: 10.1172/JCI112815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Oldendorf W. H., Cornford M. E., Brown W. J. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol. 1977 May;1(5):409–417. doi: 10.1002/ana.410010502. [DOI] [PubMed] [Google Scholar]
  53. Oldendorf W. H., Towner H. F. Blood-brain barrier and DNA changes during the evolution of experimental allergic encephalomyelitis. J Neuropathol Exp Neurol. 1974 Oct;33(5):616–631. doi: 10.1097/00005072-197410000-00004. [DOI] [PubMed] [Google Scholar]
  54. Oldstone M. B., Dixon F. J. Immunohistochemical study of allergic encephalomyelitis. Am J Pathol. 1968 Feb;52(2):251–263. [PMC free article] [PubMed] [Google Scholar]
  55. Orr E. L., Stanley N. C. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis. J Neurochem. 1989 Jul;53(1):111–118. doi: 10.1111/j.1471-4159.1989.tb07301.x. [DOI] [PubMed] [Google Scholar]
  56. Paul C., Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int J Immunopharmacol. 1995 Jun;17(6):497–503. doi: 10.1016/0192-0561(95)00034-y. [DOI] [PubMed] [Google Scholar]
  57. Pender M. P. Demyelination and neurological signs in experimental allergic encephalomyelitis. J Neuroimmunol. 1987 May;15(1):11–24. doi: 10.1016/0165-5728(87)90003-8. [DOI] [PubMed] [Google Scholar]
  58. Reese T. S., Karnovsky M. J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967 Jul;34(1):207–217. doi: 10.1083/jcb.34.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Rego A., Vargas R., Cathapermal S., Kuwahara M., Foegh M. L., Ramwell P. W. Systemic vascular effects of cyclosporin A treatment in normotensive rats. J Pharmacol Exp Ther. 1991 Nov;259(2):905–915. [PubMed] [Google Scholar]
  60. Reiber H., Suckling A. J. Cyclosporin-A treatment of experimental allergic encephalomyelitis: changes in immunological regulation and blood-CSF barrier function. J Neuroimmunol. 1986 Aug;12(2):121–130. doi: 10.1016/0165-5728(86)90025-1. [DOI] [PubMed] [Google Scholar]
  61. Sakata A., Tamai I., Kawazu K., Deguchi Y., Ohnishi T., Saheki A., Tsuji A. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol. 1994 Nov 16;48(10):1989–1992. doi: 10.1016/0006-2952(94)90601-7. [DOI] [PubMed] [Google Scholar]
  62. Scott G. S., Williams K. I., Bolton C. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis. Inflamm Res. 1996 Oct;45(10):524–529. doi: 10.1007/BF02311090. [DOI] [PubMed] [Google Scholar]
  63. Sharief M. K., Thompson E. J. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol. 1992 May;38(1-2):27–33. doi: 10.1016/0165-5728(92)90087-2. [DOI] [PubMed] [Google Scholar]
  64. Shepro D., Morel N. M. Pericyte physiology. FASEB J. 1993 Aug;7(11):1031–1038. doi: 10.1096/fasebj.7.11.8370472. [DOI] [PubMed] [Google Scholar]
  65. Stewart W. A., Alvord E. C., Hruby S., Hall L. D., Paty D. W. Early detection of experimental allergic encephalomyelitis by magnetic resonance imaging. Lancet. 1985 Oct 19;2(8460):898–898. doi: 10.1016/s0140-6736(85)90167-9. [DOI] [PubMed] [Google Scholar]
  66. Wang Q., Yang H., Miller D. W., Elmquist W. F. Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem Biophys Res Commun. 1995 Jun 26;211(3):719–726. doi: 10.1006/bbrc.1995.1872. [DOI] [PubMed] [Google Scholar]
  67. Waxman F. J., Taguiam J. M., Whitacre C. C. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine. Cell Immunol. 1984 Apr 15;85(1):82–93. doi: 10.1016/0008-8749(84)90280-6. [DOI] [PubMed] [Google Scholar]
  68. Zielasek J., Jung S., Gold R., Liew F. Y., Toyka K. V., Hartung H. P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J Neuroimmunol. 1995 Apr;58(1):81–88. doi: 10.1016/0165-5728(94)00192-q. [DOI] [PubMed] [Google Scholar]
  69. Ziylan Y. Z., LeFauconnier J. M., Bernard G., Bourre J. M. Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J Neurochem. 1988 Nov;51(5):1338–1342. doi: 10.1111/j.1471-4159.1988.tb01094.x. [DOI] [PubMed] [Google Scholar]
  70. Zloković B. V., Lipovac M. N., Begley D. J., Davson H., Rakić L. Slow penetration of thyrotropin-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain. J Neurochem. 1988 Jul;51(1):252–257. doi: 10.1111/j.1471-4159.1988.tb04864.x. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES